FDA Regulation of Blood Safety: Notification, Recall, and Enforcement Practices : Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, First Session, June 5, 1997
USGPO Staff, United States, United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources, Usgpo
U.S. Government Printing Office, 1998 - Blood - 300 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
action adverse albumin Americans areas believe biological blood and blood blood products blood safety blood supply CBER Centeon Center Chairman changes collection Committee compliance concern conducted consumer continue correct deficiency determine devices disease documentation donors Drug effective efforts EIRs enforcement ensure error and accident establishments event facilities factor FDA's Finley Food FRIEDMAN further going Government hemophilia hepatitis House Human identified immune important improve inactivation indicated industry initiated inspections inspectors involved issue June lead letter licensed look manufacturers months notification observations Office Oversight patient percent plasma fractionators plasma products potential prevent problem procedures protect question recall received recommendations regulations regulatory Relations request Resources responsibility result Right risk saline contamination Services SHAYS staff STEINHARDT Subcommittee testing Thank units viral withdrawals